Zacks Investment Research
07 Aug 2026, 16:46 UTC · 1h ago
Johnson & Johnson (JNJ) Could Be a Great Choice
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
07 Aug 2026, 16:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
The Zacks Consensus Estimate for Johnson & Johnson's 2026 earnings is $11.59 per share, representing a 7.41% year-over-year growth rate. — Positive earnings growth forecasts typically support stock price appreciation and dividend sustainability.
+0.30Johnson & Johnson has seen a share price increase of 24.17% so far this year. — Positive price momentum indicates strong recent investor confidence, though it is a lagging rather than leading indicator.
+0.10Johnson & Johnson's current annualized dividend of $5.36 is 4.3% higher than last year. — Steady dividend growth is a positive signal for income-focused investors and overall financial health.
+0.10Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company shows positive stock price growth, consistent dividend increases, and expectations for solid earnings growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
